Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, February 24, 2020
Samsung Biologics has been monitoring the COVID-19 situation closely since the initial outbreak in late January and taking proactive measures company-wide to ensure a safe working environment and continuous business operations.
read more
Monday, February 24, 2020
Dipharma Francis announced the completion of the new cGMP Quality Control laboratory and c-GMP kilolab at its CDMO site located in Kalamazoo MI.
read more
Friday, February 21, 2020
Purdue University's College of Pharmacy and Aprecia Pharmaceuticals are launching a comprehensive collaboration on future 3DP pharmaceutical equipment and medications.
read more
Thursday, February 20, 2020
Hummingbird Bioscience has signed an agreement with Mycenax Biotech for the production of material for the Phase 1 clinical trial of its HMBD-002 program.
read more
Wednesday, February 19, 2020
TCP Reliable has undergone a corporate rebranding and is now officially Integreon Global.
read more
Wednesday, February 19, 2020
Dr. Reddy’s Laboratories has entered into a definitive agreement with Wockhardt Limited to acquire select divisions of its branded generics business.
read more
Tuesday, February 18, 2020
Nucleus Biologics announced a complete line of cGMP grade media and a new supplement to enable improved insulin response and standardized processing of human pancreatic islets and beta cells.
read more
Friday, February 14, 2020
WuXi Biologics has released the following statement addressing the Coronavirus outbreak.
read more
Thursday, February 13, 2020
Rentschler Biopharma announced the hiring of Grace Kim as Vice President Business Development – North America and APAC.
read more
Thursday, February 13, 2020
Catalent announced the appointment of Jim Walter as Vice President of Operations for its Oral and Specialty Delivery business.
read more
Wednesday, February 12, 2020
Catalent has signed an agreement with Zumutor Biologics to manufacture Zumutor’s lead candidate, ZM008, for the treatment of solid tumors.
read more
Monday, February 10, 2020
Vectura Group announced Sharon Johnson has been appointed to the position of Executive Vice President for Delivery Management, a newly-created leadership role.
read more
Monday, February 10, 2020
ReForm Biologics and MilliporeSigma announced a global license agreement and collaboration to commercialize proprietary ReForm excipients used in biotherapeutic formulations.
read more
Friday, February 07, 2020
AGC Biologics and Trefoil Therapeutics announce the execution of a manufacturing contract to supply their lead compound TTHX1114.
read more
Thursday, February 06, 2020
JanOne has executed a manufacturing agreement for the formulation and manufacturing of TV1001SR, a treatment for Peripheral Artery Disease.
read more